Abstracts
Breast Cancer - Local/Regional and Adjuvant Therapy
Breast Cancer - Metastatic
Gastrointestinal (Colorectal) Cancer
Gastrointestinal (Noncolorectal) Cancer
Genitourinary Cancer
-
A randomized double-blind placebo controlled phase III trial comparing docetaxel, prednisone and placebo with docetaxel prednisone and bevacizumab in men with metastatic castrate resistant prostate cancer (metCRPC): Survival results of CALGB 90401. (#LBA4511)
Head and Neck Cancer
-
An open-label, randomized, phase III trial of zalutumumab, a human monoclonal EGF receptor antibody, versus best supportive care, in patients with non-curable squamous cell carcinoma of the head and neck who have failed standard platinum-based chemotherapy (ZALUTE). (#LBA5506)
Leukemia, Myelodysplasia, and Transplantation
Lung Cancer- Local/Regional and Adjuvant
Lung Cancer - Metastatic
Survivorship and Sarcomas
-
Long acting methylphenidate for cancer related fatigue: NCCTG trial N05C7. (#9004)
-
Increased risk of relapse with imatinib (IM) discontinuation at 5 years in advanced GIST patients : Results of the prospective BFR14 randomized phase III study comparing interruption versus continuation of IM at 5 years of treatment- a french sarcoma group. (#10032)
